Oxalate and urinary stones

World Journal of Surgery

Volumn 24, Issue 10, 2000, Pages 1154-1159

  Ogawa, Yoshihide ^a   Miyazato, Tomonori ^a   Hatano, Tadashi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CALCIUM OXALATE; GLYCOLIC ACID; GLYOXYLIC ACID; OXALIC ACID;

ARTICLE; CALCIUM OXALATE STONE; CALCULATION; CHEMICAL ANALYSIS; HUMAN; HYPEROXALURIA; METABOLISM; NEPHROLITHIASIS; PRECURSOR; STONE FORMATION; SYNTHESIS; URINARY EXCRETION; UROLITHIASIS;

HUMANS; OXALATES; URINARY CALCULI;

EID: 0033745178     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002680010193     Document Type: Article

References (51)

1. The hyperoxaluric syndromes
2. Comparison of the Equil2 Program and other methods for estimating the ion-activity product of urinary calcium oxalate: A new simplified method is proposed
3. Risk factors in urinary calcium oxalate stone formation and their relation to urinary calcium oxalate supersaturation
4. Radioenzymatic procedure for urinary oxalate determination
5. Studies on oxalate in urolithiasis. I. A radioenzymatic assay for oxalate in urine
6. Novel ion exchange chromatographic method using conductimetric detection
7. Ion-chromatographic measurement of oxalate in unprocessed urine
8. Determination of urinary oxalate by ion chromatography: Some modifications
9. Stability of ascorbate in urine: Relevance to analyses for ascorbate and oxalate
10. Evaluation of the enzymatic method using oxalate oxidase for urinary oxalate assay
11. Prevention of ascorbic acid interference in the measurement of oxalic acid in urine by ion-chromatography
12. Assay of urinary oxalate: Six methodologies compared
13. Measurement of urinary oxalate and citrate by capillary electrophoresis and indirect ultraviolet absorbance
14. Urinary oxalate and citrate determination
15. Sampling errors in the determination of urine calcium and oxalate: Solubility of calcium oxalate in HCl-urine mixtures
16. Calcium stones: Some physical and clinical aspects
17. An improved method for routine biochemical evaluation of patients with recurrent calcium oxalate stone disease
18. Nomograms for the estimation of the urine with calcium oxalate, calcium phosphate, magnesium ammonium phosphate, uric acid, sodium acid urate, ammonium acid urate, and cystine
19. Aspects on estimation of the risk of calcium oxalate crystallization in urine
20. Modification of estimation of the urinary ion-activity products of calcium oxalate and calcium phosphate
21. Equil2: A basic computer program for the calculation of urinary saturation
22. Estimation of the state of saturation of brushite and calcium oxalate in urine: A comparison of 3 methods
23. Idiopathic calcium urinary lithiasis: Usefulness of Parks' and Tiselius' indices in the evaluation of the risk of stone formation
24. Urinary calcium oxalate saturation in 'stone formers' and normal subjects: An application of the Equil2 program
25. Circadian rhythm of lithogenic substances in the urine
26. Diurnal variation in calcium-oxalate supersaturation level in normal and stone-forming urine
27. Diurnal variations of calcium, phosphorus, and magnesium in normal and calcium oxalate stone-forming urine
28. Circadian variations in the risk of urinary calcium oxalate stone formation
29. Impact of sodium-potassium citrate on the diurnal variations in urinary calcium oxalate and calcium phosphate saturation levels in normal individuals
30. Calcium oxalate crystalization levels among pediatric patients
31. Oxalate metabolism in stone formers
32. Oxalate content in common Japanese foods
33. Glycolate in the diet and its conversion to urinary oxalate in the rat
34. Pharmacological approaches in the treatment of primary hyperoxaluria
35. Hyperoxaluria and renal insufficiency due to ascorbic acid administration during total parenteral nutrition
36. 14 in man
37. Enzymatic studies on ascorbic acid catabolism in animals. 1. Catabolism of 2,3-diketo-L-gulonic acid
38. 14 acid
39. Urinary oxalic acid excretion by man following ingestion of large amounts of ascorbic acid
40. Risk of oxalate stones from extra large doses of vitamin C
41. Effect of megadoses of ascorbic acid on serum and urinary oxalate
42. Evolution and the need for ascorbic acid
43. The safety of high vitamin C intakes in man
44. A possible role for ascorbate in calculi formation
45. Ascorbic acid overdosing: A risk factor for calcium oxalate nephrolithiasis
46. Effect of high dose vitamin C on urinary oxalate levels
47. No contribution of ascorbic acid to renal calcium oxalate stones
48. The relation between urinary tract infections and stone composition in renal stone formers
49. Genetic aspects of urolithiasis
50. Advances in the enzymology and molecular genetics of primary hyperoxaluria type 1: Prospects for gene therapy
51. Variable peroxisomal and mitochondrial targeting of alanine: Glyoxylate aminotransferase in mammalian evolution and disease